menu
Prefilled Syringes Market is estimated to be worth over USD 2.5 billion in 2030
Prefilled Syringes Market is estimated to be worth over USD 2.5 billion in 2030
Despite having been available for more than two decades, the demand for prefilled syringes continues to grow, given the numerous benefits they offer over conventional injectable drug delivery systems

RootsAnalysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringes Market (5th Edition),2020-2030.

The  report features an extensive study of thecurrent market landscape of prefilled syringes and the likely futureopportunities associated with such devices, over the next 10-12 years. Itfeatures an in-depth analysis, highlighting the capabilities of variousstakeholders engaged in this domain. In addition to other elements, the studyincludes:

·       A detailed overview of the current marketlandscape of companies engaged in manufacturing prefilled syringes.

·       A detailed overview of the current marketlandscape of companies that are developing drugs in combination with prefilledsyringes.

·       A detailed competitiveness analysis of thevarious prefilled syringes that we came across..

·       A list of marketed drugs / therapies andpipeline candidates that are likely to be developed in combination withprefilled syringes in the near future.

·       An analysis presenting potential strategicpartners (primarily drug developers) for prefilled syringe manufacturers (withregard to likely collaboration opportunities for combination productdevelopment).

·       An analysis of the various prefilled syringecombination product-related initiatives of big pharma players.

·       A review of the landscape of contract fill /finish services providers that offer services for prefilled syringes, featuringa list of active (large-sized) service providers and analysis based on a numberof relevant parameters.

·       An informative summary of various guidelinesestablished and issued by major regulatory bodies for the approval of prefilledsyringes, across different countries / geographical regions.

·       Brief discussions of currently availablespecialty syringes.

·       A case study on companies that are engaged inthe manufacturing of autoinjectors.

·       Elaborate profiles of prominent prefilledsyringe manufacturers engaged in this domain.

Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)

Targettherapeutic area

·       Autoimmune disorders

·       Infectious diseases

·       Neurological disorders

·       Blood disorders

·       Oncological disorders

·       Psychiatric disorders

·       Respiratory disorders

·       Cardiovascular disorders

·       Metabolic disorders

·       Ophthalmic diseases

·       Orthopedic disorders

·       Others

Typeof syringe

·       Specialty syringes

Typeof syringe barrel material

·       Glass

·       Plastic

Numberof barrel chambers

·       Single chamber

·       Dual chamber

Keygeographical regions

·       North America

·       Europe

·       Latin America

·       Asia Pacific

·       Middle East and Africa World

Transcriptsof interviews held with the following senior level representatives ofstakeholder companies

·       Matthew Young, Founder and Chief TechnologyOfficer, Oval Medical Technologies

·       Kirti Maheshwari, Chief Technical Officer,Intas Pharmaceuticals

·       Gregor Kawaletz, Chief Commercial Officer,IDT Biologika

·       Kevin Cancelliere and Tibor Hlobik, MarketingDirectors, West Pharmaceutical

·       Marco Pederiva, Marketing & SalesDirector, Lonstroff

·       Jesse Fourt, Design Director, IDEO

·       Anonymous, Chief Executive Officer,Small-sized Medical Device Company

Keycompanies covered in the report

·       Becton Dickinson

·       West Pharmaceutical

·       Gerresheimer

·       Ompi

·       Schott

·       Nipro

·       WEGO Prefills Pharmaceutical Packaging

·       Taisei Kako

·       Terumo

·       Aguettant

·       Arte

·       JO Pharma

·       Pfizer Injectables

·       Shandong Pharmaceutical Glass

·       Shandong Zibo Minkang Pharmaceutical Packing

·       Vetter Pharma

Requestfor PDF Sample:

https://www.rootsanalysis.com/reports/284/request-sample.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

 

AlsoVisit Our Latest Publication

Human Microbiome Market

In Silico / Computer-Aided DrugDiscovery Services Market

Antibody Contract Manufacturing Market

Biopharma Contract Manufacturing Market

Cell Therapy Manufacturing Market